M&A Deal Summary |
|
|---|---|
| Date | 2015-02-27 |
| Target | United Dutch Breweries |
| Sector | Beverages |
| Buyer(s) | GIMV |
| Sellers(s) | Egeria |
| Deal Type | Secondary Buyout |
| Advisor(s) | Stamford Partners LLP (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1980 |
| PE ASSETS | 2.0B EUR |
| Size | Large |
| Type | Sector Agnostic |
GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.
| DEAL STATS | # |
|---|---|
| Overall | 91 of 158 |
| Sector (Beverages) | 1 of 1 |
| Type (Secondary Buyout) | 14 of 24 |
| Country (Netherlands) | 25 of 39 |
| Year (2015) | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-02-13 |
ActoGeniX NV
Zwijnaarde, Belgium ActoGenix develops therapies, based on its patented TopAct™ technology platform, which address major diseases requiring intensive medical care, including gastrointestinal problems, auto-immunity diseases, allergies and metabolic disorders. TopAct™ uses micro-organisms for the oral administration of proteins. ActoGeniX’s first product – for treating Crohn’s disease - has already been successfully tested on patients. |
Sell | $60M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-04-23 |
Euretco BV
Hoevelaken, Netherlands Euretco BV is a dynamic retail organization in the non-food retail sector, directed at independent entrepreneurs, and through its own retail activities, also at consumers. T |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.7B EUR |
| Size | Large |
| Type | Sector Agnostic |
Egeria is a private equity and real estate investment firm. The Firm operates a variety of investment funds focused on opportunities throughout Western Europe and North America. The Firm's private equity group principally looks to invest in companies located in the Netherlands, Germany, Austria, and Switzerland valued up to €350 million. Egeria looks for companies with stable cash flows, experienced management, and strong growth potential. Egeria is sector agnostic, however, the firm will not consider investing in biotech, software, or 'non-ethical' sectors. Egeria was formed in 1997 and is based in Amsterdam.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 26 |
| Sector (Beverages) | 2 of 2 |
| Type (Secondary Buyout) | 4 of 11 |
| Country (Netherlands) | 8 of 20 |
| Year (2015) | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-01-01 |
Royal Sanders
Vlijmen, Netherlands Royal Sanders is a manufacturer and distributor of personal care products such as skin care, bath & shower, hair care, body care, deodorants, sun care, fragrances and oral care. Royal Sanders was founded in 1851 and is based in Vlijmen, Netherlands. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-04-29 |
Mirror Controls International B.V.
Woerden, Netherlands Mirror Controls International B.V. is a provider of motorised actuators for exterior automotive mirror systems. The company is a Tier 2 component specialist, supplying to the global mirror system suppliers from manufacturing operations in Ireland, Mexico and China. |
Sell | $494M |
